Country: United Kingdom
Language: English
Source: VMD (Veterinary Medicines Directorate)
Lincomycin, Neomycin
Huvepharma N.V.
Lincomycin, Neomycin
Intramammary solution
POM-V - Prescription Only Medicine – Veterinarian
Cattle
Antimicrobial intramammary
Authorized
2000-01-04
Revised: August 2019 AN: 01677/2018 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Albiotic 330 mg / 100 mg Intramammary Solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCES per syringe (10 ml) Lincomycin (as Lincomycin hydrochloride) 330 mg Neomycin (as Neomycin sulphate) 100 mg EXCIPIENTS Disodium edetate 5 mg For the full list of excipients, see Section 6.1 3. PHARMACEUTICAL FORM Intramammary solution 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Lactating cow 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of mastitis in lactating cattle. The product is effective against Staphylococcus species (both penicillinase and non-penicillinase producers) including Staphylococcus aureus, Streptococcus species including Streptococcus agalactiae, Streptococcus dysgalactiae and Streptococcus uberis, and coliform bacteria including Escherichia coli. 4.3 CONTRAINDICATIONS None 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None Revised: August 2019 AN: 01677/2018 Page 2 of 5 4.5 SPECIAL PRECAUTIONS FOR USE i. Special precautions for use in animals None ii. Special precautions to be taken by the person administering the veterinary medicinal product to animals Avoid contact with the solution. Wash hands and any exposed skin immediately after use. 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) None known 4.7 USE DURING PREGNANCY, LACTATION, OR LAY No restrictions. 4.8 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION This product should not be used concomitantly with macrolides e.g. erythromycin, because lincomycin and the macrolides antagonise each other at the site of action, the 50S ribosomal sub-unit. 4.9 AMOUNTS TO BE ADMINISTERED AND ADMINISTRATION ROUTE Dosage: infuse one syringe (10 ml. product) into each affected quarter. Repeat this treatment immediately after each of the next two 12 hourly milkings, to give a total of three infusions per infected quarter. Administration: by intramammary infusion only, taking a Read the complete document